New Delhi, January 16
Serum Institute of India (SII) CEO Adar Poonawalla on Saturday wished Prime Minister Narendra Modi success in launching the vaccination rollout in the country.
“I wish India and Sri Narendra Modi ji great success in launching the world’s largest COVID vaccination roll-out. It brings me great pride that #COVISHIELD is part of this historic effort and to endorse its safety and efficacy, I join our health workers in taking the vaccine myself,” Poonawalla tweeted while posting a video in which he was seen receiving the vaccine shot.
The drugs regulatory body of India has currently approved two vaccines. Pune-based Serum Institute of India has developed the Covishield vaccine developed by AstraZeneca and Oxford University while the Covaxin has been developed by Hyderabad’s Bharat Biotech in collaboration with the Indian Medical Council of research (ICMR) and National Institute of Virology.
I wish India & Sri @narendramodi ji great success in launching the world’s largest COVID vaccination roll-out. It brings me great pride that #COVISHIELD is part of this historic effort & to endorse it’s safety & efficacy, I join our health workers in taking the vaccine myself. pic.twitter.com/X7sNxjQBN6
— Adar Poonawalla (@adarpoonawalla) January 16, 2021
Earlier in the day, the Prime Minister launched India’s vaccination drive against the novel coronavirus via video conferencing.
Billed as the world’s largest vaccination program, covering the entire length and breadth of the country, the drive aims to first inoculate millions of its healthcare and frontline workers and reach an estimated 3 crore people by the end of its first phase.
A total of 3006 session sites across all states and union territories will be virtually connected during the launch. Around 100 beneficiaries will be vaccinated at each session site on the inaugural day, the union health ministry had said.
In the first phase government and private sector health care workers, including Integrated Child Development Services (ICDS) workers, will receive the vaccine. — ANI